Vignesh Raman

Dr. Vignesh Raman


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 September 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
VRVignesh Raman
Vignesh Raman
MRMahesh Ramanan
Mahesh Ramanan
FEFelicity Edwards
Felicity Edwards
FEFelicity Edwards
Felicity Edwards
Amongst critically ill patients managed in the intensive care unit (ICU) setting, disorders of sodium and water balance, or dysnatraemias, are commonly encountered either at time of admission or during ICU stay. There is extensive literature associating both extremities of incident dysnatraemia, hyponatraemia, and hypernatremia, with higher mortality and morbidity amongst a range of ICU disease populations. Therefore, a comprehensive understanding of sodium homeostasis mechanisms, effects of deranged sodium physiology, comprehensive diagnostic workup, and avoidance of suboptimal management are paramount to the critical care clinician. This narrative review incorporated a PubMed search to summarise contemporary literature perspectives of (a) sodium homeostasis mechanisms, (b) descriptions of dysnatraemia, (c) ICU-specific challenges to dysnatraemia diagnosis, (d) associated clinical outcomes in critically ill populations, and (e) ongoing paucity to deranged sodium physiology literature relevant to daily ICU practice. The purpose of this review is to both guide critical care clinicians towards performing a diagnostic approach to dysnatraemia with integrated physiology for a tailored treatment strategy as well as highlight ongoing research priorities in the realm of deranged sodium physiology.

17 June 2022 in Anz Journal of Surgery
Verified
Journal Article
Closed access
VRVignesh Raman
Vignesh Raman
MJManasi Jiwrajka
Manasi Jiwrajka
CPCliff Pollard
Cliff Pollard
DGDavid A. Grieve
David A. Grieve
HAHamish Alexander
Hamish Alexander
MRMichael Redmond
Michael Redmond

17 January 2022 in Anz Journal of Surgery
Verified
Journal Article
Closed access
PDF file
VRVignesh Raman
Vignesh Raman
MJManasi Jiwrajka
Manasi Jiwrajka
CPCliff Pollard
Cliff Pollard
DGDavid A Grieve
David A Grieve
HAHamish Alexander
Hamish Alexander
MRMichael Redmond
Michael Redmond

1 October 2020 in Chest
Verified
Journal Article
Open access
PDF file
CMChristopher Mosher
Christopher Mosher
MNMichael Nanna
Michael Nanna
OJOliver Jawitz
Oliver Jawitz
VRVignesh Raman
Vignesh Raman
NFNorma Farrow
Norma Farrow
EMEvan Myers
Evan Myers
SESSION TITLE: Pulmonary Rehabilitation Posters

26 July 2022 in Trauma Care
Verified
Journal Article
Open access
PDF file
VRVignesh Raman
Vignesh Raman
MBMatthew Bright
Matthew Bright
GMGary Mitchell
Gary Mitchell
Background: Severe traumatic brain injury (TBI) management begins in the pre-hospital setting, but clinicians are left with limited options for stabilisation during retrieval due to time and space constraints, as well as a lack of access to monitoring equipment. Bolus osmotherapy with hypertonic substances is commonly utilised as a temporising measure for life-threatening brain herniation, but much contention persists around its use, largely stemming from a limited evidence base. Method: The authors conducted a brief review of hypertonic substance use in patients with TBI, with a particular focus on studies involving the pre-hospital and emergency department (ED) settings. We aimed to report pragmatic information useful for clinicians involved in the early management of this patient group. Results: We reviewed the literature around the pharmacology of bolus osmotherapy, commercially available agents, potential pitfalls, supporting evidence and guideline recommendations. We further reviewed what the ideal agent is, when it should be administered, dosing and treatment endpoints and/or whether it confers meaningful long-term outcome benefits. Conclusions: There is a limited evidence-based argument in support of the implementation of bolus osmotherapy in the pre-hospital or ED settings for patients who sustain a TBI. However, decades’ worth of positive clinician experiences with osmotherapy for TBI will likely continue to drive its on-going use. Choices regarding osmotherapy will likely continue to be led by local policies, individual patient characteristics and clinician preferences.